- Home
- RNA vs RMR Comparison
RNA vs RMR Comparison
Compare RNA & RMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RNA | RMR |
|---|---|---|
| Founded | 2012 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 227.6M | 253.9M |
| IPO Year | 2025 | 2015 |
Fundamental Metrics
Financial Performance| Metric | RNA | RMR |
|---|---|---|
| Price | $13.08 | $15.92 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 20 | 2 |
| Target Price | ★ $69.26 | $19.00 |
| AVG Volume (30 Days) | ★ 2.1M | 136.7K |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | N/A | ★ 11.12% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.71 |
| Revenue | N/A | ★ $700,284,000.00 |
| Revenue This Year | $88.12 | $274.80 |
| Revenue Next Year | $18.11 | $3.85 |
| P/E Ratio | ★ N/A | $22.80 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $13.06 | $13.48 |
| 52 Week High | $73.06 | $18.09 |
Technical Indicators
Market Signals| Indicator | RNA | RMR |
|---|---|---|
| Relative Strength Index (RSI) | 5.61 | 42.60 |
| Support Level | $13.06 | $15.86 |
| Resistance Level | $72.52 | $16.84 |
| Average True Range (ATR) | 1.05 | 0.45 |
| MACD | -0.24 | -0.10 |
| Stochastic Oscillator | 3.62 | 11.76 |
Price Performance
Historical ComparisonAbout RNA Avidity Biosciences Inc.
Atrium Therapeutics Inc is a biopharmaceutical firm focused on developing RNA-based therapeutics for cardiac conditions, including cardiomyopathies. Its platform technology is designed to enable targeted delivery of RNA therapeutics to heart tissue by combining ligand-based targeting approaches with oligonucleotide-based therapies. The company's development pipeline includes programs targeting genetically associated forms of cardiomyopathy, specifically involving the PRKAG2 and PLN genes.
About RMR The RMR Group Inc.
The RMR Group Inc is a holding company that conducts its business through its subsidiary, which is an alternative asset management company that invests in real estate and manages real estate-related businesses. Its business consists of providing management services to publicly owned real estate investment trusts, or REITs, and real estate-related operating companies. It also provides management services to real estate securities mutual funds and commercial real estate finance companies. The company's operating segment is RMR LLC and All Other Operations. The RMR Group derives its revenue from providing business and property management services as well as advisory and other services.